Share on StockTwits

Research analysts at Roth Capital reduced their price objective on shares of Masimo Corp. (NASDAQ:MASI) from $32.00 to $28.00 in a report released on Friday. Roth Capital’s price objective points to a potential upside of 15.56% from the company’s current price.

Masimo Corp. (NASDAQ:MASI) traded down 10.32% during mid-day trading on Friday, hitting $21.73. 2,018,073 shares of the company’s stock traded hands. Masimo Corp. has a 1-year low of $19.30 and a 1-year high of $32.20. The stock has a 50-day moving average of $24.01 and a 200-day moving average of $25.79. The company has a market cap of $1.233 billion and a price-to-earnings ratio of 21.42.

Masimo Corp. (NASDAQ:MASI) last released its earnings data on Thursday, August 7th. The company reported $0.24 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.29 by $0.05. The company had revenue of $140.92 million for the quarter, compared to the consensus estimate of $145.76 million. During the same quarter last year, the company posted $0.30 earnings per share. Masimo Corp.’s revenue was up 2.5% compared to the same quarter last year. Analysts expect that Masimo Corp. will post $1.28 EPS for the current fiscal year.

Several other analysts have also recently commented on the stock. Analysts at Piper Jaffray downgraded shares of Masimo Corp. from an “overweight” rating to a “neutral” rating in a research note on Friday. Analysts at BTIG Research initiated coverage on shares of Masimo Corp. in a research note on Tuesday, July 8th. They set a “buy” rating and a $32.00 price target on the stock. Three equities research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. Masimo Corp. has an average rating of “Hold” and an average target price of $27.80.

Masimo Corporation is a global medical technology company that develops, manufactures, and markets noninvasive patient monitoring products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.